SCHEMBL31711252

SCHEMBL31711252

CCCc1cc(C(=O)N2Cc3ccccc3C(c3cnn(C)c3)C2)no1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 3/20 0.46
▸ TP53 P04637 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ S1PR1 P21453 2/20 0.37
▸ S1PR3 Q99500 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ XBP1 P17861 1/20 0.37
▸ RAB9A P51151 8/20 0.37
▸ NPC1 O15118 5/20 0.37
▸ LMNA P02545 1/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ HSP90AA1 P07900 2/20 0.36
▸ SCD5 Q86SK9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31711218 0.86 CHRNA4 (0.42) KMT2AMAPTHTTTSHRSLC6A2
SCHEMBL27252088 0.83 NPC1 (0.53) KMT2AMEN1MAPTHTTSMN1; SMN2
SCHEMBL31710983 0.83 SCD5 (0.39) NPSR1KMT2AMEN1MAPTHTT
SCHEMBL27252087 0.83 NPSR1 (0.46) NPSR1TP53KMT2AMEN1MAPT
SCHEMBL31711143 0.83 NPC1 (0.53) KMT2AMEN1MAPTHTTSMN1; SMN2
SCHEMBL31711348 0.83 NPSR1 (0.46) NPSR1TP53KMT2AMEN1MAPT
SCHEMBL31711024 0.83 NPC1 (0.53) KMT2AMEN1MAPTHTTSMN1; SMN2
SCHEMBL31711221 0.83 SLC6A2 (0.38) NPSR1KMT2AMEN1MAPTHTT
SCHEMBL27252143 0.83 NPSR1 (0.46) NPSR1TP53KMT2AMEN1MAPT
SCHEMBL27252150 0.83 NPSR1 (0.46) NPSR1TP53KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325534-A1 MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2025-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325534-A1 MICROBIOCIDAL TETRAHYDROISOQUINOLINE DERIVATIVES IFNG, NOX1, CYP1A1 NPSR1 2996/4885TP53 1835/4885KMT2A 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback